Simultaneous determination of lamivudine and stavudine in antiretroviral fixed dose combinations by first derivative spectrophotometry and high performance liquid chromatography

Journal of Pharmaceutical and Biomedical Analysis

Volumn 41, Issue 3, 2006, Pages 761-765

  Kapoor, Namita ^a   Khandavilli, Sateesh ^a   Panchagnula, Ramesh ^a  

^a NATIONAL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH NIPER   (India)

Author keywords

First derivative spectroscopy; Fixed dose combinations (FDCs); HPLC; Lamivudine (3TC); Stavudine (d4T); Zero crossing measurements

Indexed keywords

ANTIRETROVIRUS AGENT; LAMIVIR S 30; LAMIVUDINE; METHANOL; STAVUDINE; VIROLIS 30; WATER;

ACCURACY; ARTICLE; DRUG FORMULATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; PRIORITY JOURNAL; QUALITY CONTROL; REPRODUCIBILITY; SPECTROPHOTOMETRY; ULTRAVIOLET SPECTROPHOTOMETRY;

CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG COMBINATIONS; LAMIVUDINE; REFERENCE STANDARDS; REPRODUCIBILITY OF RESULTS; REVERSE TRANSCRIPTASE INHIBITORS; SENSITIVITY AND SPECIFICITY; SPECTROPHOTOMETRY, ULTRAVIOLET; STAVUDINE;

EID: 33646429483     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpba.2006.01.007     Document Type: Article

References (14)

1. Panchagnula R., Agrawal S., Ashokraj Y., Varma M., Sateesh K., Bhardwaj V., Bedi S., Gulati I., Parmar J., Kaul C.L., Blomberg B., Fourie B., Roscigno G., Wire R., Laing R., Evans P., and Moore T. Methods Find. Exp. Clin. Pharmacol. 26 (2004) 703-721
2. http://www.fda.gov, Guidance for Industry Fixed Dose Combination and Co-packaged Drug Products for treatment of HIV, 2004.
3. S. Raffanti, D. Haas, in: A.G. Gilman, T.W. Rall, A.S. Nies, P. Taylor (Eds.), The Pharmacological Basis of Therapeutics, New York, 1990, pp. 1349-1380.
4. Erk N. Pharmazie 59 (2004) 106-111
5. Uslu B., and Ozkan S. Anal. Chim. Acta 466 (2002) 175-182
6. Indian Pharmacopoeia 1996 (Addendum 2002) Govt. of India, Ministry of Health and Family Welfare, Controller of Publications, Delhi, 1996, pp. 930-938.
7. Indian Pharmacopoeia 1996 (Addendum 2002) Govt. of India, Ministry of Health and Family Welfare, Controller of Publications, Delhi, 1996, p. 913.
8. Morris D., and Selinger K. J. Pharm. Biomed. Anal. 12 (1994) 255-264
9. Kaul S., Stouffer B., Mummaneni V., Turabi N., Mantha S., Jayatilak P., and Barbhaiya R. J. Pharm. Biomed. Anal. 15 (1996) 165-174
10. Rezk N., Tidwell R., and Kashuba A. J. Chromatogr. B 791 (2003) 137-144
11. Gorog S. Ultraviolet-visible Spectrophotometry in Pharmaceutical Analysis (1995), CRC Press 114-138
12. Panchagnula R., Kaur K., Sood A., and Singh I. Pharm. Sci. 3 (1997) 425-429
13. Varma M., Kapoor N., Sarkar M., and Panchagnula R. J. Chromatogr. B 813 (2004) 347-352
14. http://www.ich.org, Validation of analytical procedures: methodology, ICH guideline Q2B, 2003.